Co-associations between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology

Metabolism: Clinical and Experimental

Volumn 57, Issue 9, 2008, Pages 1190-1197

  Godsland, Ian F ^a   Johnston, Desmond G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; ENZYME ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FACTORIAL ANALYSIS; HEMATOLOGY; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LEUKOCYTE COUNT; LINEAR REGRESSION ANALYSIS; LIVER FUNCTION; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR;

BLOOD; CLUSTER ANALYSIS; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FACTOR ANALYSIS, STATISTICAL; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; URIC ACID;

EID: 48849093484     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.04.010     Document Type: Article

References (45)

1. Greenland P. Critical questions about the metabolic syndrome. Circulation 112 (2005) 3675-3676
2. Sattar N. The metabolic syndrome: should current criteria influence clinical practice?. Curr Opin Lipidol 17 (2006) 404-411
3. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
4. Ferrannini E. Metabolic syndrome: a solution in search of a problem. J Clin Endocrinol Metab 92 (2007) 396-398
5. Reaven G. Banting lecture: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
6. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
7. Sarafidis P.A., and Bakris G.L. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?. J Hum Hypertens 21 (2007) 12-19
8. Sarafidis P.A., and Bakris G.L. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance?. Am J Nephrol 27 (2007) 44-54
9. Lawlor D.A., Ebrahim S., May M., and Davey Smith G. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol 159 (2004) 1013-1018
10. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
11. Ford E.S. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168 (2003) 351-358
12. Facchini F.S., Carantoni M., Jeppesen J., and Reaven G.M. Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinaemia in healthy, non-obese men and women. Metabolism 47 (1998) 831-835
13. Godsland I.F., Leyva F., Worthington M., Walton C., and Stevenson J.C. Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). J Intern Med 244 (1998) 33-41
14. Bergman R.N., Ider Y.Z., Bowden C.R., and Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 236 (1979) E667-E677
15. Godsland I.F., Agbaje O.F., and Hovorka R. Evaluation of nonlinear regression approaches to estimation of insulin sensitivity by the minimal model with reference to Bayesian hierarchical analysis. Am J Physiol Endocrinol Metab 291 (2006) E167-E174
16. Swan J., Walton C., and Godsland I.F. Assessment of insulin sensitivity in man: a comparison of minimal model and euglycaemic clamp derived measures in health and heart failure. Clin Sci 86 (1994) 317-322
17. Leyva F., Godsland I.F., Walton C., Worthington M., and Stevenson J.C. Factors of the metabolic syndrome-baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Arterioscler Throm Vasc Biol 18 (1998) 208-214
18. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
19. Hanley A.J., Karter A.J., Williams K., Festa A., D'Agostino R.B., Wagenknecht L.E., et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 112 (2005) 3713-3721
20. Godsland I.F., Bruce R., Jeffs J.A.R., Leyva F., Walton C., and Stevenson J.C. Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study. Int J Cardiol 97 (2004) 543-550
21. Leyva F., Godsland I.F., Ghatei M., Proudler A.J., Aldis S., Walton C., et al. Hyperleptinaemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18 (1998) 928-933
22. Godsland I.F., Crook D., Proudler A.J., and Stevenson J.C. Hemostatic risk factors and insulin sensitivity, regional body fat distribution and the metabolic syndrome. J Clin Endocrinol Metab 90 (2005) 190-197
23. Godsland I.F., Rosankiewicz J.R., Proudler A.J., and Johnston D.G. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 86 (2001) 719-723
24. Facchini F., Chen Y.D., Hollenbeck C.B., and Reaven G.M. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266 (1991) 3008-3011
25. Martin J.V., Hague R.V., and Martin P.J. The association between serum triglycerides and gamma glutamyl transpeptidase activity in diabetes mellitus. Clin Biochem 9 (1976) 208-211
26. Wannamethee G., Ebrahim S., and Shaper A.G. Gamma-glutamyltransferase: determinants and association with mortality from ischaemic heart disease and all causes. Am J Epidemiol 142 (1995) 699-708
27. Rantala A.O., Lilja M., Kauma H., Savolainen M.J., Reunanen A., and Kesäniemi Y.A. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med 248 (2000) 230-238
28. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Bonadonna R.C., et al. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes 27 (2003) 1283-1289
29. Vozarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., Bogardus C., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 1889-1895
30. Thamer C., Tschritter O., Haap M., Shirkavand F., Machann J., Fritsche A., et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res 37 (2005) 246-251
31. Angelico F., del Ben M., Conti R., Francioso S., Feole K., Maccioni D., et al. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic disease. J Gastroenterol Hepatol 18 (2003) 588-594
32. Karp D.R., Shimooku K., and Lipsky P.E. Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem 276 (2001) 3798-3804
33. Carantoni M., Abbasi F., Warmerdam F., Klebanov M., Wang P.W., Chen Y.D., et al. Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler Thromb Vasc Biol 18 (1998) 762-767
34. Sattar N., Scherbakova O., Ford I., O'Reilly D.S., Stanley A., Forrest E., et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 53 (2004) 2855-2860
35. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino R.B.J., Kempf J., et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 53 (2004) 2623-2632
36. Facchini F., Hollenbeck C.B., Chen Y.N., Chen Y.D., and Reaven G.M. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 232 (1992) 267-272
37. Festa A., D'Agostino R.J., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
38. Juhan-Vague I., Thompson S.G., and Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. Arterioscler Thromb 13 (1993) 1865-1873
39. Moan A., Nordby G., Os I., Birkeland K.I., and Kjeldsen S.E. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism 43 (1994) 423-427
40. Catalano C., Muscelli E., Natali A., Mazzoni A., Masoni A., Bernadini B., et al. Reciprocal association between insulin sensitivity and the haematocrit in man. Eur J Clin Invest 27 (1997) 634-637
41. Hoieggen A., Fossum E., Moan A., Enger E., and Kjeldsen S.E. Whole-blood viscosity and the insulin-resistance syndrome. J Hypertens 16 (1998) 203-210
42. Barbieri M., Ragno E., Benvenuti E., Zito G.A., Corsi A., Ferrucci L., et al. New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 44 (2001) 1232-1237
43. Choi K.M., Lee J., Kim Y.H., Kim K.B., Kim D.L., Kim S.G., et al. Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study. Diabetes Res Clin Pract 60 (2003) 205-212
44. Hanley A.J., Karter A.J., Festa A., D'Agostino R.J., Wagenknecht L.E., Savage P., et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 51 (2002) 2642-2647
45. Pladevall M., Singal B., Williams L.K., Brotons C., Guyer H., Sadurni J., et al. A single factor underlies the metabolic syndrome. Diabetes Care 29 (2006) 113-122